OBJECTIVE: To describe our initial experience with single-port laparoscopic myomectomy (SP-LM) using transumbilical GelPort access and the surgical technique used, and to evaluate the safety and feasibility of this procedure. STUDY DESIGN: A prospective observational study was performed at a university teaching hospital from January 2009 to December 2009. Fifteen patients with symptomatic subserosal or superficial intramural myomas (≤ 8 cm) underwent SP-LM. RESULTS: The mean age and body mass index were 35.0 ± 8.6 years and 22.6 ± 2.6 kg/m². Two patients had a history of previous abdominal surgery, consisting of one and two cesarean deliveries. The mean operating time, hemoglobin change, return of bowel activity, and length of hospital stay were 81 ± 21.5 min, 1.1 ± 0.5 g/dL, 34.3 ± 5.9 h, and 3.1 ± 0.5 days, respectively. In one patient (6.7%), SP-LM was converted to two-port LM. There were no surgical or wound complications in any patient, and the histopathological result was leiomyoma in all the cases. CONCLUSION: SP-LM is feasible in selected patients with symptomatic myoma.
OBJECTIVE: To describe our initial experience with single-port laparoscopic myomectomy (SP-LM) using transumbilical GelPort access and the surgical technique used, and to evaluate the safety and feasibility of this procedure. STUDY DESIGN: A prospective observational study was performed at a university teaching hospital from January 2009 to December 2009. Fifteen patients with symptomatic subserosal or superficial intramural myomas (≤ 8 cm) underwent SP-LM. RESULTS: The mean age and body mass index were 35.0 ± 8.6 years and 22.6 ± 2.6 kg/m². Two patients had a history of previous abdominal surgery, consisting of one and two cesarean deliveries. The mean operating time, hemoglobin change, return of bowel activity, and length of hospital stay were 81 ± 21.5 min, 1.1 ± 0.5 g/dL, 34.3 ± 5.9 h, and 3.1 ± 0.5 days, respectively. In one patient (6.7%), SP-LM was converted to two-port LM. There were no surgical or wound complications in any patient, and the histopathological result was leiomyoma in all the cases. CONCLUSION:SP-LM is feasible in selected patients with symptomatic myoma.
Authors: Su Mi Kim; Jong Min Baek; Eun Kyung Park; In Cheul Jeung; Ji Hyang Choi; Chan Joo Kim; Yong Seok Lee Journal: JSLS Date: 2015 Sep-Dec Impact factor: 2.172